SHAREHOLDER ALERT: WeissLaw LLP Reminds UROV, CIT, HLIX, and CBLI Shareholders About Its Ongoing Investigations

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors ofUrovant Sciences Ltd. (NASDAQ: UROV)in connection with the proposed interested-party acquisition of the company by Sumitovant Biopharma Ltd., UROV's majority shareholder that currently owns 72% of the company's outstanding common shares.